ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,283,000 | +37.2% | 52,639 | -19.8% | 0.09% | +56.9% |
Q4 2018 | $935,000 | -49.7% | 65,609 | -46.3% | 0.06% | -58.6% |
Q3 2018 | $1,859,000 | +543.3% | 122,287 | +591.0% | 0.14% | +600.0% |
Q1 2018 | $289,000 | -80.2% | 17,697 | -84.5% | 0.02% | -87.5% |
Q4 2017 | $1,457,000 | +301.4% | 113,813 | +175.4% | 0.16% | +180.7% |
Q4 2016 | $363,000 | -61.1% | 41,332 | -79.8% | 0.06% | -28.8% |
Q3 2015 | $933,000 | +60.9% | 204,612 | +154.2% | 0.08% | +23.1% |
Q2 2015 | $580,000 | -8.7% | 80,493 | -6.6% | 0.06% | 0.0% |
Q1 2015 | $635,000 | – | 86,212 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |